InvestorLens

AUPH — AURINIA PHARMACEUTICALS INC

Public company

Sign in to save3 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About AURINIA PHARMACEUTICALS INC (AUPH)

AURINIA PHARMACEUTICALS INC (AUPH) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $16M. Across recent filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in AUPH

100
/100
Strong Institutional Accumulation
Added / Increased6
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track AUPH

20
/100
Emerging Interest
3investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

AUPH Ownership Composition

How AURINIA PHARMACEUTICALS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
100% of tracked value
Institutions
3
tracked investors
Total Reported
$9.2M
combined 13F value
Sectors1
  • Other100.0%
Other(3)
100.0%

Tracked investors reporting AUPH

  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    406.7K
    Value
    $6M
    % Portfolio
    0.00%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    117.2K
    Value
    $1.7M
    % Portfolio
    0.00%
  • Paul Tudor JonesMar 31, 2026
    Tudor Investment Corp
    Shares
    98.6K
    Value
    $1.5M
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold AUPH?
3 tracked institutional investors disclosed a position in AUPH (AURINIA PHARMACEUTICALS INC) in their most recent 13F filing.
Who is the largest institutional holder of AUPH?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in AUPH, valued at $16M.
Did institutional ownership of AUPH increase or decrease?
Across recent 13F filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 0 fully exited AUPH.
Where does this AUPH ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.